The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Episcleritis and scleritis: clinical features and treatment results
Open accessAbstract
PURPOSE: To evaluate the clinical experience with episcleritis and scleritis at a tertiary care eye center. METHODS: Retrospective chart review. RESULTS: One hundred thirty-four patients with scleral inflammation were seen over a 12-year period. Thirty-seven patients had episcleritis, and 97 patients had scleritis. Ocular complications occurred in only 13.5% of patients with episcleritis but in 58.8% of patients with scleritis (P <.0001). No patient with episcleritis had a decrease in visual acuity, whereas 15.9% of patients with scleritis did. Only 16.7% of patients with episcleritis required more than topical corticosteroids for treatment, and these patients required oral nonsteroidal anti-inflammatory drugs. Conversely, 30.4% of patients with scleritis required nonsteroidal anti-inflammatory drugs, 31.9% oral prednisone, and 26.1% systemic immunosuppressive drugs (P <.0001). Necrotizing scleritis and posterior scleritis more often were associated with ocular complications, occurring in 91.7% and 85.7%, respectively, than were diffuse anterior scleritis and nodular anterior scleritis (P =.020). Patients with necrotizing scleritis and posterior scleritis were more likely to be treated with oral corticosteroids or immunosuppressive drugs (90% and 100%, respectively) than were patients with diffuse anterior scleritis and nodular anterior scleritis (56.4% and 21.4%, respectively, P =.002). CONCLUSIONS: Scleritis is a severe ocular inflammation, often associated with ocular complications, and nearly always treated with systemic medications. Nearly 60% of these patients will need oral corticosteroids or immunosuppressive drugs to control the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Watson, P. G., & Hayreh, S. S. (1976) · British Journal of Ophthalmology · doi:10.1136/bjo.60.3.163 · Cited by 602
Guillevin, L., Cordier, J., Lhote, F., Cohen, P., Jarrousse, B., Royer, I., Lesavre, P., Jacquot, C., Bindi, P., Bielefeld, P., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401213 · Cited by 509
Severity of Scleritis and Episcleritis
de la Maza, M. S., Jabbur, N. S., & Foster, C. S. (1994) · Ophthalmology · doi:10.1016/s0161-6420(94)31325-x · Cited by 211
McGavin, D. D., Williamson, J., Forrester, J. V., Foulds, W. S., Buchanan, W. W., Dick, W. C., Lee, P., MacSween, R. N., & Whaley, K. (1976) · British Journal of Ophthalmology · doi:10.1136/bjo.60.3.192 · Cited by 202
Benson, W. E. (1988) · Survey of Ophthalmology · doi:10.1016/0039-6257(88)90093-8 · Cited by 200
Cited by
Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
Kim, S. J., Flach, A. J., & Jampol, L. M. (2010) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.07.005 · Cited by 383
Larsen, S., Bendtzen, K., & Nielsen, O. H. (2010) · Annals of Medicine · doi:10.3109/07853890903559724 · Cited by 303
Clinical Spectrum of HLA-B27-Associated Ocular Inflammation
Pathanapitoon, K., Dodds, E. M., Cunningham, E. T., & Rothova, A. (2017) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2016.1185527 · Cited by 75
Metadata
- Authors
- Jabs, D. A., Mudun, A., Dunn, J. P., & Marsh, M. J.
- Venue
- American Journal of Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2000-10
- Volume
- 130
- Issue
- 4
- Pages
- 469-476
- ISSN
- 0002-9394 (ISSN-L)
- OpenAlex
- W2067260112
- Cited by
- 392
- References
- 5
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Episcleritis and scleritis: clinical features and treatment results. https://app.cochat.ai/papers/10.1016/s0002-9394(00)00710-8
- The paper
- Jabs, D. A., Mudun, A., Dunn, J. P., & Marsh, M. J. (2000). Episcleritis and scleritis: clinical features and treatment results. American Journal of Ophthalmology. https://doi.org/10.1016/s0002-9394(00)00710-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.